These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15466364)

  • 1. Mechanisms mediating insulin resistance in transgenic mice overexpressing mouse apolipoprotein A-II.
    Castellani LW; Gargalovic P; Febbraio M; Charugundla S; Jien ML; Lusis AJ
    J Lipid Res; 2004 Dec; 45(12):2377-87. PubMed ID: 15466364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance.
    Castellani LW; Goto AM; Lusis AJ
    Diabetes; 2001 Mar; 50(3):643-51. PubMed ID: 11246886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of HDL deficiency in mice overexpressing human apoA-II.
    Julve J; Escolà-Gil JC; Ribas V; González-Sastre F; Ordóñez-Llanos J; Sánchez-Quesada JL; Blanco-Vaca F
    J Lipid Res; 2002 Oct; 43(10):1734-42. PubMed ID: 12364558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate.
    Ribas V; Palomer X; Roglans N; Rotllan N; Fievet C; Tailleux A; Julve J; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
    Biochim Biophys Acta; 2005 Dec; 1737(2-3):130-7. PubMed ID: 16226489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased production of very-low-density lipoproteins in transgenic mice overexpressing human apolipoprotein A-II and fed with a high-fat diet.
    Julve J; Escolà-Gil JC; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    Biochim Biophys Acta; 2000 Nov; 1488(3):233-44. PubMed ID: 11082533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoA-II modulates the association of HDL with class B scavenger receptors SR-BI and CD36.
    de Beer MC; Castellani LW; Cai L; Stromberg AJ; de Beer FC; van der Westhuyzen DR
    J Lipid Res; 2004 Apr; 45(4):706-15. PubMed ID: 14729860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
    Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
    J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
    Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
    J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.
    Hedrick CC; Castellani LW; Warden CH; Puppione DL; Lusis AJ
    J Biol Chem; 1993 Sep; 268(27):20676-82. PubMed ID: 8376417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein A-II, genetic variation on chromosome 1q21-q24, and disease susceptibility.
    Martín-Campos JM; Escolà-Gil JC; Ribas V; Blanco-Vaca F
    Curr Opin Lipidol; 2004 Jun; 15(3):247-53. PubMed ID: 15166779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance involvement in prevalence of familial dysbetalipoproteinemia in ε2ε2 subjects by Bayesian network modeling.
    Corsetti JP; Love TM; Sparks CE; Bakker SJL; Dullaart RPF
    Clin Biochem; 2018 Sep; 59():31-36. PubMed ID: 29928902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro transcriptional induction of the human apolipoprotein A-II gene by glucose.
    Sauvaget D; Chauffeton V; Dugué-Pujol S; Kalopissis AD; Guillet-Deniau I; Foufelle F; Chambaz J; Leturque A; Cardot P; Ribeiro A
    Diabetes; 2004 Mar; 53(3):672-8. PubMed ID: 14988251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice.
    Schultz JR; Gong EL; McCall MR; Nichols AV; Clift SM; Rubin EM
    J Biol Chem; 1992 Oct; 267(30):21630-6. PubMed ID: 1400473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol homeostatic mechanisms in transgenic mice with altered expression of apoproteins A-I, A-II and A-IV.
    Kalopissis AD; Chambaz J
    Int J Tissue React; 2000; 22(2-3):67-78. PubMed ID: 10937356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II.
    Warden CH; Hedrick CC; Qiao JH; Castellani LW; Lusis AJ
    Science; 1993 Jul; 261(5120):469-72. PubMed ID: 8332912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions.
    Hedrick CC; Castellani LW; Wong H; Lusis AJ
    J Lipid Res; 2001 Apr; 42(4):563-70. PubMed ID: 11290828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice.
    Héron-Milhavet L; Haluzik M; Yakar S; Gavrilova O; Pack S; Jou WC; Ibrahimi A; Kim H; Hunt D; Yau D; Asghar Z; Joseph J; Wheeler MB; Abumrad NA; LeRoith D
    Endocrinology; 2004 Oct; 145(10):4667-76. PubMed ID: 15231693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis.
    Boisfer E; Lambert G; Atger V; Tran NQ; Pastier D; Benetollo C; Trottier JF; Beaucamps I; Antonucci M; Laplaud M; Griglio S; Chambaz J; Kalopissis AD
    J Biol Chem; 1999 Apr; 274(17):11564-72. PubMed ID: 10206963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.